Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Stavudine and Tenofovir Regimens in South African HIV Patients
NCT01601899Phase 4Terminated
- Sponsor
- University of the Witwatersrand
- Start
- Oct 2008
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV) (3 arms), sponsored by University of the Witwatersrand. Primary endpoints: Changes in mitochondrial DNA copy number in adipocyte tissue at 4 weeks, Changes in gene expression in adipocyte tissue at 4 weeks and 3 more. Started Oct 2008; status: terminated.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01601899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01601899.